Skip to content
Insurance, Medical Health Aged Care

GMHBA celebrates a hat-trick! Geelong private health insurer wins Canstar Outstanding Value Award for the third year in a row.

GMHBA 2 mins read

Monday 30 September 2024

 

GMHBA has claimed the Canstar Outstanding Value Award – Hospital Cover (VIC) in the annual Canstar Health Insurance Awards for the third consecutive year.

The awards are based on Canstar’s Star Ratings and recognise the insurers found to offer outstanding value to consumers. Canstar compared 32 different private health insurers including 3,683 hospital and 4,275 extras policy variations.

The research team commended GMHBA for its ability to cater to a wide range of policyholders with diverse healthcare needs.

GMHBA CEO David Greig said GMHBA had supported members through more than 90,000 hospital admissions and almost 62,000 surgeries in the past financial year alone.

“Last financial year GMHBA paid $402 million in hospital and medical claims, and this represents life changing access to health care and financial support for our members,” he said.

“We are committed to helping our members access the healthcare they need, and have invested significantly in providing great products, services and experiences. Over the next 12 months, we’ll be launching a new suite of extras products that will complement our award-winning hospital products and offer our members better value and more choice depending on their cover needs.”

GMHBA supports more than 320,000 members nationally and has expanded its offering beyond private health insurance. The leading not-for-profit regional health insurer will open a second multidisciplinary GMHBA Hub in Geelong in October, improving accessibility to regional Victorians and bringing together services such as dental, eye care, medical, and physiotherapy under the one roof.

“We are also investing significantly in technology that will equip our people with leading edge capabilities to deliver best in class experiences for our members and patients,” Mr Greig added.

The annual Canstar Health Insurance Awards is considered the gold standard in the health insurance industry, showcasing excellence in value, coverage, and customer satisfaction.

 


About us:

About GMHBA

GMHBA is an Australian not for profit health insurance and care company. We have served the community since 1934, and with 90 years’ experience, we have become Australia’s leading regionally based not for profit private health insurer.  Through our personalised approach and exceptional customer service, we put the health and wellbeing of our members and communities first. Our approach is guided by our philosophy, Healthier Together and decisions are made with our members first and foremost in mind.
GMHBA has a Health and Branch network spanning Western Victoria, with sites in Bendigo, Ballarat, Geelong, Portland and Warrnambool.


Contact details:

GMHBA Head of Corporate Communications Meg Rayner: 0458 418 823 or megrayner@gmhba.com.au

More information: https://www.canstar.com.au/star-ratings-awards/health-insurance/

Media

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.